Richard Klausner, Director at Juno Therapeutics, Inc. (JUNO), sold 47,240 shares at $40.39 ($1.9M) on 2016-03-02, disclosed to the SEC on 2016-03-02.
Open-market sale of $1.9M JUNO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.39 | 23,240 | $939K | 49.2% |
| 2 | $40.39 | 23,240 | $939K | 49.2% |
| 3 | $41.22 | 760 | $31K | 1.6% |
| Total | $40.40 avg | 47,240 | $1.9M | 100% |
| Filing → |
| LYEL | SELL | 2022-09-27 | $71K | — | Filing → |
| JUNO | SELL | 2018-01-09 | $1.2M | — | Filing → |
| JUNO | SELL | 2017-12-22 | $3.2M | — | Filing → |